Calvarial defect healing by recruitment of autogenous osteogenic stem cells using locally applied simvastatin

Biomaterials

Volumn 34, Issue 37, 2013, Pages 9373-9380

  Yueyi, Cui ^a   Xiaoguang, Han ^a   Jingying, Wang ^a   Quansheng, Song ^a   Jie, Tan ^b   Xin, Fu ^b   Yingsheng, Xu ^a   Chunli, Song ^a,b  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b Beijing Key Laboratory of Digital Media   (China)

Author keywords

BMP 2; Bone healing; Endothelial progenitor cells; HIF 1 ; Mesenchymal stem cell; Simvastatin

Indexed keywords

BMP-2; BONE HEALING; ENDOTHELIAL PROGENITOR CELLS; MESENCHYMAL STEM CELL; SIMVASTATIN;

BLOOD; CELL CULTURE; STEM CELLS;

BONE;

BONE MORPHOGENETIC PROTEIN 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; POLYGLYCOLIC ACID; SIMVASTATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL HOMING; CELL MIGRATION; CONTROLLED STUDY; DRUG EFFECT; DRUG IMPLANT; ENDOTHELIAL PROGENITOR CELL; FRACTURE HEALING; IN VITRO STUDY; MESENCHYMAL STEM CELL; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKULL DEFECT; STEM CELL MOBILIZATION;

BMP-2; BONE HEALING; ENDOTHELIAL PROGENITOR CELLS; HIF-1Α; MESENCHYMAL STEM CELL; SIMVASTATIN;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CELL MOVEMENT; CELLS, CULTURED; DRUG IMPLANTS; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HYPOLIPIDEMIC AGENTS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS; RABBITS; SIMVASTATIN; SKULL; STEM CELLS; WOUND HEALING;

EID: 84884817735     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.08.060     Document Type: Article

References (54)

1. Dimitriou R., Mataliotakis G.I., Angoules A.G., Kanakaris N.K., Giannoudis P.V. Complications following autologous bone graft harvesting from the iliac crest and using the RIA: a systematic review. Injury 2011, 42:S3-S15.
2. Niemeyer P., Fechner K., Milz S., Richter W., Suedkamp N.P., Mehlhorn A.T., et al. Comparison of mesenchymal stem cells from bone marrow and adipose tissue for bone regeneration in a critical size defect of the sheep tibia and the influence of platelet-rich plasma. Biomaterials 2010, 31:3572-3579.
3. Grellier M., Granja P.L., Fricain J.C., Bidarra S.J., Renard M., Bareille R., et al. The effect of the co-immobilization of human osteoprogenitors and endothelial cells within alginate microspheres on mineralization in a bone defect. Biomaterials 2009, 30:3271-3278.
4. Rankin S.M. Impact of bone marrow on respiratory disease. Curr Opin Pharmacol 2008, 8:236-241.
5. Orlic D., Kajstura J., Chimenti S., Bodine D.M., Leri A., Anversa P. Bone marrow stem cells regenerate infarcted myocardium. Pediatr Transplant 2003, 7:86-88.
6. Kumar S., Ponnazhagan S. Mobilization of bone marrow mesenchymal stem cells invivo augments bone healing in a mouse model of segmental bone defect. Bone 2012, 50:1012-1018.
7. Mundy G., Garrett R., Harris S., Chan J., Chen D., Rossini G., et al. Stimulation of bone formation invitro and in rodents by statins. Science 1999, 286:1946-1949.
8. Park J.B. The use of simvastatin in bone regeneration. Med Oral Patol Oral Cir Bucal 2009, 14:485-489.
9. Chuengsamarn S., Rattanamongkoulgul S., Suwanwalaikorn S., Wattanasirichaigoon S., Kaufman L. Effects of statins vs. non-statin lipid-lowering therapy on bone formation and bone mineral density biomarkers in patients with hyperlipidemia. Bone 2010, 46:1011-1015.
10. Tanigo T., Takaoka R., Tabata Y. Sustained release of water-insoluble simvastatin from biodegradable hydrogel augments bone regeneration. JControl Release 2010, 143:201-206.
11. Patil S., Holt G., Raby N., McLellan A.R., Smith K., O'Kane S., et al. Prospective, double blind, randomized, controlled trial of simvastatin in human fracture healing. JOrthop Res 2009, 27:281-285.
12. Ma B., Clarke S.A., Brooks R.A., Rushton N. The effect of simvastatin on bone formation and ceramic resorption in a peri-implant defect model. Acta Biomater 2008, 4:149-155.
13. Yao W., Farmer R., Cooper R., Chmielewski P.A., Tian X.Y., Setterberg R.B., et al. Simvastatin did not prevent nor restore ovariectomy-induced bone loss in adult rats. JMusculoskelet Neuronal Interact 2006, 6:277-283.
14. Obi C., Wysokinski W., Karnicki K., Owen W.G., McBane R.D. Inhibition of platelet-rich arterial thrombus invivo acute antithrombotic effect of intravenous HMG-CoA reductase therapy. Arterioscler Thromb Vasc Biol 2009, 29:1271-1276.
15. Fukui T., Ii M., Shoji T., Matsumoto T., Mifune Y., Kawakami Y., et al. Therapeutic effect of local administration of low-dose simvastatin-conjugated gelatin hydrogel for fracture healing. JBone Miner Res 2012, 27:1118-1131.
16. Pauly S., Luttosch F., Morawski M., Haas N.P., Schmidmaier G., Wildemann B. Simvastatin locally applied from a biodegradable coating of osteosynthetic implants improves fracture healing comparable to BMP-2 application. Bone 2009, 45:505-511.
17. Rojbani H., Nyan M., Ohya K., Kasugai S. Evaluation of the osteoconductivity of α-tricalcium phosphate, β-tricalcium phosphate, and hydroxyapatite combined with or without simvastatin in rat calvarial defect. JBiomed Mater Res A 2011, 98:488-498.
18. Tanabe K., Nomoto H., Okumori N., Miura T., Yoshinari M. Osteogenic effect of fluvastatin combined with biodegradable gelatin-hydrogel. Dent Mater J 2012, 31:489-493.
19. Llevadot J., Murasawa S., Kureishi Y., Uchida S., Masuda H., Kawamoto A., et al. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. JClin Invest 2001, 108:399-405.
20. Li Y., Zhang D., Zhang Y., He G., Zhang F. Augmentation of neovascularization in murine hindlimb ischemia by combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells transplantation. JBiomed Sci 2010, 17:75.
21. Yang Y.J., Qian H.Y., Huang J., Li J.J., Gao R.L., Dou K.F., et al. Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine hearts. Arterioscler Thromb Vasc Biol 2009, 29:2076-2082.
22. Han X., Yang N., Cui Y., Xu Y., Dang G., Song C. Simvastatin mobilizes bone marrow stromal cells migrating to injured areas and promotes functional recovery after spinal cord injury in the rat. Neurosci Lett 2012, 521:136-141.
23. Song C., Wang J., Song Q., Li X., Chen Z., Ma Q., et al. Simvastatin induces estrogen receptor-alpha (ER-α) in murine bone marrow stromal cells. JBone Miner Metab 2008, 26:213-217.
24. Wang W., Zhang X., Zheng J., Yang J. High glucose stimulates adipogenic and inhibits osteogenic differentiation in MG-63 cells through cAMP/protein kinase A/extracellular signal-regulated kinase pathway. Mol Cell Biochem 2010, 338:115-122.
25. Patel M., Dunn T.A., Tostanoski S., Fisher J.P. Cyclic acetal hydroxyapatite composites and endogenous osteogenic gene expression of rat marrow stromal cells. JTissue Eng Regen Med 2010, 4:422-436.
26. Wan J., Lu L.J., Miao R., Liu J., Xu X.X., Yang T., et al. Alterations of bone marrow-derived endothelial progenitor cells following acute pulmonary embolism in mice. Exp Biol Med 2010, 235:989-998.
27. Tang Y., Wu X., Lei W., Pang L., Wan C., Shi Z., et al. TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med 2009, 15:757-765.
28. López-Marure R., Contreras P.G., Dillon J.S. Effects of dehydroepiandrosterone on proliferation, migration, and death of breast cancer cells. Eur J Pharmacol 2011, 660:268-274.
29. Salem H.K., Thiemermann C. Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 2010, 28:585-596.
30. Orlic D., Kajstura J., Chimenti S., Limana F., Jakoniuk I., Quaini F., et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 2001, 98:10344-10349.
31. Shyu W.C., Lin S.Z., Yang H.I., Tzeng Y.S., Pang C.Y., Yen P.S., et al. Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells. Circulation 2004, 110:1847-1854.
32. Kollet O., Shivtiel S., Chen Y.Q., Suriawinata J., Thung S.N., Dabeva M.D., et al. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. JClin Invest 2003, 112:160-169.
33. Machaliński B., Paczkowska E., Koziarska D., Ratajczak M.Z. Mobilization of human hematopoietic stem/progenitor-enriched CD34+ cells into peripheral blood during stress related to ischemic stroke. Folia Histochem Cytobiol 2006, 44:97-101.
34. Reichert J.C., Saifzadeh S., Wullschleger M.E., Epari D.R., Schütz M.A., Duda G.N., et al. The challenge of establishing preclinical models for segmental bone defect research. Biomaterials 2009, 30:2149-2163.
35. Song C., Guo Z., Ma Q., Chen Z., Liu Z., Jia H., et al. Simvastatin induces osteoblastic differentiation and inhibits adipocytic differentiation in mouse bone marrow stromal cells. Biochem Biophys Res Commun 2003, 308:458-462.
36. Athanasiou K.A., Niederauer G.G., Agrawal C. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials 1996, 17:93-102.
37. Rasal R.M., Janorkar A.V., Hirt D.E. Poly (lactic acid) modifications. Prog Polym Sci 2010, 35:338-356.
38. Zhang F., Qiu T., Wu X., Wan C., Shi W., Wang Y., et al. Sustained BMP signaling in osteoblasts stimulates bone formation by promoting angiogenesis and osteoblast differentiation. JBone Miner Res 2009, 24:1224-1233.
39. Atesok K., Li R., Stewart D.J., Schemitsch E.H. Endothelial progenitor cells promote fracture healing in a segmental bone defect model. JOrthop Res 2010, 28:1007-1014.
40. Lee D.Y., Cho T.J., Kim J.A., Lee H.R., Yoo W.J., Chung C.Y., et al. Mobilization of endothelial progenitor cells in fracture healing and distraction osteogenesis. Bone 2008, 42:932-941.
41. Toupadakis C.A., Wong A., Genetos D.C., Chung D.J., Murugesh D., Anderson M.J., et al. Long-term administration of AMD3100, an antagonist of SDF-1/CXCR4 signaling, alters fracture repair. JOrthop Res 2012, 30:1853-1859.
42. Ma X.L., Sun X.L., Wan C.Y., Ma J.X., Tian P. Significance of circulating endothelial progenitor cells in patients with fracture healing process. JOrthop Res 2012, 30:1860-1866.
43. Dimitriou R., Tsiridis E., Giannoudis P.V. Current concepts of molecular aspects of bone healing. Injury 2005, 36:1392-1404.
44. Wang B., Sun L., Tian Y., Li Z., Wei H., Wang D., et al. Effects of atorvastatin in the regulation of circulating EPCs and angiogenesis in traumatic brain injury in rats. JNeurol Sci 2012, 319:117-123.
45. Walter D.H., Rittig K., Bahlmann F.H., Kirchmair R., Silver M., Murayama T., et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002, 105:3017-3024.
46. Chen Y.J., Wurtz T., Wang C.J., Kuo Y.R., Yang K.D., Huang H.C., et al. Recruitment of mesenchymal stem cells and expression of TGF-beta 1 and VEGF in the early stage of shock wave-promoted bone regeneration of segmental defect in rats. JOrthop Res 2004, 22:526-534.
47. Dégano I.R., Vilalta M., Bagó J.R., Matthies A.M., Hubbell J.A., Dimitriou H., et al. Bioluminescence imaging of calvarial bone repair using bone marrow and adipose tissue-derived mesenchymal stem cells. Biomaterials 2008, 29:427-437.
48. Ceradini D.J., Gurtner G.C. Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc Med 2005, 15:57-63.
49. Dai Y., Ashraf M., Zuo S., Uemura R., Dai Y.S., Wang Y., et al. Mobilized bone marrow progenitor cells serve as donors of cytoprotective genes for cardiac repair. JMol Cell Cardiol 2008, 44:607-617.
50. Zampetaki A., Kirton J.P., Xu Q. Vascular repair by endothelial progenitor cells. Cardiovasc Res 2008, 78:413-421.
51. Adams J.M., Difazio L.T., Rolandelli R.H., Luján J.J., Haskó G., Csóka B., et al. HIF-1: a key mediator in hypoxia. Acta Physiol Hung 2009, 96:19-28.
52. Otsuru S., Tamai K., Yamazaki T., Yoshikawa H., Kaneda Y. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway. Stem Cells 2008, 26:223-234.
53. Yano S., Kuroda S., Shichinohe H., Hida K., Iwasaki Y. Do bone marrow stromal cells proliferate after transplantation into mice cerebral infarct? -a double labeling study. Brain Res 2005, 1065:60-67.
54. Shichinohe H., Kuroda S., Lee J.B., Nishimura G., Yano S., Seki T., et al. Invivo tracking of bone marrow stromal cells transplanted into mice cerebral infarct by fluorescence optical imaging. Brain Res Brain Res Protoc 2004, 13:166-175.